Clinical Trial Update: Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating Nt-proBNP-guided primary prevention of cardiovascular events in patients with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Heart Failure

Snippet

Sponsor: Medical University of Vienna | Conditions: Diabetes Mellitus, Heart Failure | Phase 2, Phase 3 | Status: COMPLETED